Galena Biopharma (GALE)

Add to Watchlists
Create an Alert
0.4401 -0.01  -2.72% NASDAQ Jul 26, 16:59 Delayed 2m USD

Galena Biopharma Price to Book Value:

6.447 for July 26, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Galena Biopharma Price to Book Value Chart

Export Data
Save Image

Galena Biopharma Historical Price to Book Value Data

View and export this data going back to 2008. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 26, 2016 6.447
July 25, 2016 6.627
July 22, 2016 6.592
July 21, 2016 6.885
July 20, 2016 7.112
July 19, 2016 5.583
July 18, 2016 5.899
July 15, 2016 5.931
July 14, 2016 5.988
July 13, 2016 6.005
July 12, 2016 6.240
July 11, 2016 6.681
July 8, 2016 6.671
July 7, 2016 7.538
July 6, 2016 8.624
July 5, 2016 9.668
July 1, 2016 9.046
June 30, 2016 6.828
June 29, 2016 5.127
June 28, 2016 29.74
June 27, 2016 29.44
June 24, 2016 30.76
June 23, 2016 31.50
June 22, 2016 33.25
June 21, 2016 32.96
June 20, 2016 33.25
   
June 17, 2016 32.52
June 16, 2016 31.50
June 15, 2016 30.62
June 14, 2016 30.32
June 13, 2016 31.06
June 10, 2016 30.47
June 9, 2016 29.00
June 8, 2016 30.03
June 7, 2016 29.59
June 6, 2016 30.91
June 3, 2016 31.06
June 2, 2016 30.62
June 1, 2016 31.64
May 31, 2016 26.51
May 27, 2016 25.34
May 26, 2016 24.90
May 25, 2016 25.20
May 24, 2016 25.49
May 23, 2016 24.46
May 20, 2016 22.27
May 19, 2016 20.95
May 18, 2016 21.68
May 17, 2016 19.19
May 16, 2016 19.19
May 13, 2016 18.90

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

GALE Price to Book Value Benchmarks

Companies
Ampliphi Biosciences 1.390
Clovis Oncology 2.295
Actinium Pharmaceuticals 4.026

GALE Price to Book Value Range, Past 5 Years

Minimum 2.051 Jan 05 2012
Maximum 139.06 Jan 16 2014
Average 12.18

GALE Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("GALE", "price_to_book_value")
  • Last 5 data points: =YCS("GALE", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.